Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-17

Clinical Trial Update: A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating camrelizumab with microwave ablation and chemotherapy for colorectal cancer with liver or lung metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Camrelizumab (camrelizumab)

Snippet

Sponsor: Harbin Medical University | Conditions: Colorectal Cancer Metastatic, Liver Metastases | Phase 2 | Status: UNKNOWN